Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Powering Precision Health (PPH) is an independent, non-profit organization and global think tank dedicated to advancing the field of precision medicine through biomarker innovation. Founded by life sciences visionary Kevin Hrusovsky, the organization hosts an annual international summit that brings together leading scientists, physicians, and investors to share research on early disease detection and personalized treatment. PPH focuses on the intersection of technological capabilities and medical research across therapeutic areas such as oncology, neurology, and cardiology. The movement aims to transform healthcare from a reactive model to a proactive one centered on prevention and early intervention. By fostering collaboration among industry stakeholders, PPH seeks to accelerate the adoption of ultra-sensitive biomarker technologies to improve patient outcomes globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Powering Precision Health.